Novavax COVID Vaccine Likely To Be Approved For Emergency Use, Awaits WHO approval
Novavax reportedly has completed the process of submitting the necessary documents of "NVX-CoV2373", a protein-based COVID-19 vaccine to the World Health Organisation's (WHO) emergency use list. Moreover, the company is also expecting regulators in other countries to decide on its vaccine, to begin shipping doses. "Novavax's, partner Serum Institute of India has already manufactured millions of doses that are ready for shipment", said an official of the company.